# China NMPA Inspection - National Medical Products Administration - December 02, 2021

Source: https://www.globalkeysolutions.net/records/china_inspection/national-medical-products-administration/461252cc-dbe4-487d-93ba-20e328d3b955/
Source feed: China

> China NMPA unannounced inspection for National Medical Products Administration published December 02, 2021. The Sichuan Provincial Drug Administration, through a notice dated November 19, 2021, and published on December 2, 2021, forwarded a directive from th

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Notice from the Office of the Sichuan Provincial Drug Administration Regarding Forwarding the "Announcement from the National Medical Products Administration on Ceasing the Sale of Cosmetics Labeled as Bayuncao Fule Nursing Cream (Soothing and Repairing Type)"
- Company Name: National Medical Products Administration
- Publication Date: 2021-12-02
- Product Type: cosmetics
- Summary: The Sichuan Provincial Drug Administration, through a notice dated November 19, 2021, and published on December 2, 2021, forwarded a directive from the National Medical Products Administration (NMPA). This NMPA Announcement (No. 84 of 2021) mandates the immediate cessation of sales for the cosmetic product known as "Bayuncao Fule Nursing Cream (Soothing Repair Type)." The document does not specify the direct cause for the sales halt but indicates issues requiring regulatory intervention. The regulatory framework involves the NMPA issuing the primary ban, which is then disseminated to provincial and local market supervision administrations for enforcement across China. The focus is on retailers and distributors of the affected product, rather than a single inspected company. Required actions for all market supervision bodies include intensifying inspections of businesses, ordering the immediate removal of the product from sale, meticulously examining purchase and inspection records, imposing severe penalties for any identified illegal activities, and transferring cases with suspected criminal elements to public security organs. This directive highlights the robust regulatory oversight of cosmetic products.

Company: https://www.globalkeysolutions.net/companies/national-medical-products-administration/6e6c9c0b-c8e5-4330-aec0-ab84e891e2fd/